Indigenous people disproportionately suffer from higher rates of diabetes,[@bib1], [@bib2] hypertension,[@bib3] and chronic kidney disease (CKD),[@bib4], [@bib5] and are also at higher risk for kidney failure.[@bib6] These conditions are associated with multiple comorbidities and early mortality,[@bib7] with CKD and kidney failure representing a disproportionate economic burden for the health care system.

Although these longstanding and intergenerational health disparities between Indigenous individuals and the general population are well described,[@bib8], [@bib9] it is in the most isolated communities that disparities are particularly prominent.[@bib10], [@bib11] Individuals living in isolated areas are disproportionately faced with social inequalities such as poverty and poor access to services[@bib12]; as such, geography may not be the primary determinant driving these observed health disparities, but rather may be a surrogate for other social determinants. However, as it is unclear how rates of diabetes, hypertension, and CKD differ by geographic area, there is a knowledge gap with regard to identifying the underlying mechanisms that contribute to higher rates of CKD and other comorbidities in Indigenous populations in Canada.

The First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) was a mobile, Indigenous-led, cross-sectional screening program that provided community-wide screening for CKD, diabetes, elevated blood pressure, and kidney failure risk prediction, as well as risk-based counseling, in rural and remote communities in Manitoba, Canada.[@bib13] An urban arm of the study was subsequently launched by an interdisciplinary clinical team from NorWest Co-op Community Health Centre, as part of the NorWest Mobile Diabetes and Kidney Disease Screening and Intervention Project, in low-income areas in the city of Winnipeg, Manitoba, Canada. The objective of the current report was to compare rates of diabetes, elevated blood pressure, and CKD among Indigenous urban, rural, and remote dwellers.

Methods {#sec1}
=======

Study Population {#sec1.1}
----------------

The Canadian health care system is a complex system of policies and governing relationships between federal and provincial legislating authorities, with most people covered by universal health coverage under the Canadian Health Act, administered by the provinces. However, health coverage for Indigenous people is a complicated facet, steeped in a long historical context. Public health and preventive services are provided by the federal First Nations and Inuit Health Branch (FNIHB) to indigenous people who are registered under the Indian Act of Canada and who live on reserves and on traditional territories. Among Indigenous Canadians who have registered or obtained treaty status, roughly 44% live on more than 3100 Indigenous reserves across Canada, which are mostly located in either rural or remote locations. For Indigenous people living off-reserves, mainly in urban locations, health care services are provided by the provincial health care system, although the FNIHB provides noninsured health benefits, such as dental and vision coverage to registered Indigenous people regardless of their dwelling location.[@bib14]

Manitoba is a prairie province in central Canada with a population of 1.2 million people, 17% of whom are of Indigenous ancestry. Roughly two-fifths of the Indigenous population reside in the province's capital city, Winnipeg, the largest city in the province and home to the largest proportion of Indigenous individuals among major Canadian cities, at 11% of the municipal population. For the current study, screening occurred within rural (accessible by road) and remote (accessible only by plane or, in winter, by ice roads) communities, as well as within selected areas in the urban city of Winnipeg, including the downtown core, as well as within the North-West quadrant of the city. These urban areas are low-income areas, with median family incomes ranging from \$29,696 to \$61,414, far below the median income of the city (\$81,880).

The FINISHED and the NorWest Co-op Community Health Centre Screening Programs {#sec1.2}
-----------------------------------------------------------------------------

The FINISHED screening program was executed across 11 Indigenous rural and remote communities within 2 tribal councils in Manitoba, Canada. This has previously been described in detail.[@bib13] All adults 18 to 80 years of age were invited to participate in the screening program, and were recruited from community gathering centers, as well as through door-to-door recruitment. Between March 2013 and January 2015, a total of 716 individuals in 7 rural communities and 630 individuals in 4 remote communities were screened, with a compliance rate of 23%. An additional 284 individuals of Indigenous descent were screened as part of the NorWest Mobile Diabetes and Kidney Disease Screening and Intervention Project, through the Norwest Co-op Community Health Centre, an ongoing screening initiative targeting Indigenous as well as other ethnic and at-risk urban populations. Through various community-based partnerships, screening teams consisting of interdisciplinary health care professionals set up mobile clinics at 13 accessible sites in selected low-income areas in Winnipeg. Screening occurred between May 2015 and December 2016, and although promotion of the screening program was tailored for each site, overall it was targeted toward individuals who were unlikely to have a primary care provider. In both screening programs, individuals were screened regardless of whether they presented with known kidney disease risk factors, such as diabetes, elevated blood pressure, or family history of kidney disease. Mobile screening and point-of-care testing were used, which allowed for quick risk prediction, and appropriate referrals to be made to primary care and specialist services. In the urban arm of the study, partnerships with community organizations and primary care supports allowed the clinical teams to make additional referrals to a variety of counseling supports.

Ethics approval was granted by the University of Manitoba Health Research Ethics Board (HS16070), as well as from the NorWest Co-op Community Health Board of Directors, the Diabetes Integration Project Board of Directors, and the Tribal Council leaders and government leaders of the Indigenous communities in the rural and remote areas where screening occurred. Imperatively, Indigenous research principles of Ownership, Control, Access and Possession (OCAP) were stringently followed for the duration of the screening programs.

Data Collection and Study Definitions {#sec1.3}
-------------------------------------

In both screening initiatives, several data elements were collected during screening, including the following: participants' age, sex, diastolic and systolic blood pressures, estimated glomerular filtration rate (eGFR; measured using the Chronic Kidney Disease Epidemiology Collaboration \[CKD-EPI\] equation), glycated hemoglobin (HbA~1c~), serum creatinine, and urine albumin to creatinine ratio (ACR). The Kidney Failure Risk Equation (KFRE), a validated multivariate model that predicts a patient's risk of developing kidney failure within the next 5 years using patient age, sex, urine ACR, and eGFR, was used to rank patients into categories of no current risk, low risk, intermediate risk, and high risk ([Supplementary Figure S1](#appsec1){ref-type="sec"}).[@bib15]

Data Analyses {#sec1.4}
-------------

Descriptive statistics for screening results, presented by geographic area, are expressed as mean ± SD for normal categorical variables; median and interquartile ranges for nonnormal variables; and percentages for continuous variables. At the bivariate level, cross-tabulations were conducted to compare geographical groups: χ^2^ statistics were used for categorical variables, and either analyses of variance for normally distributed continuous variables, or the Kruskal−Wallis test for non−normally distributed variables, were used. In addition, using the Kidney Disease: Improving Global Outcomes (KDIGO) "heat map" staging system, CKD risk was visually summarized for individuals in each of the 3 geographic areas.[@bib16] At the multivariate level, logistic regressions were conducted, comparing rural and remote communities to the urban population as the reference group. Odds ratios and 95% confidence intervals are presented, with age and sex controlled for in all regression analyses.

Results {#sec2}
=======

Demographic Characteristics {#sec2.1}
---------------------------

In total, 1872 Indigenous people were screened as part of the FINISHED and NorWest initiatives: 716 in rural (accessible by road) communities, 630 in remote (accessible by plane) communities, and 284 in low-income areas of Winnipeg. The rural and remote screening results have previously been published[@bib17]; descriptive statistics for all geographic locations are presented in [Table 1](#tbl1){ref-type="table"}. Individuals screened in the urban arm were the youngest (mean age 40.6 years), and were predominantly female (63.4%). In comparison, rural-dwelling individuals had a mean age of 45.2 years, and 59.3% were female. Remote-dwelling screenees had a mean age of 44.6 years, and 62.2% were female.Table 1Descriptive statistics comparing Indigenous Canadians living in urban, rural, and remote locationsVariableUrban Indigenous (n = 284)Rural Indigenous (n = 716)Remote Indigenous (n = 630)*P* valuesAge, yr40.6 ± 13.545.2 ± 14.444.6 ± 14.6\<0.0001Sex, % female63.4%59.3%62.2%0.4HbA~1c~, % ≥6.5%14.1%28.9%42.1%\<0.0001eGFR, ml/min per 1.73 m^2^106.5 ± 22.4105.6 ± 20.4107.2 ± 22.90.4eGFR, ml/min per 1.73 m^2^ (% \< 60)2.8%2.8%4.0%0.4Urine ACR, mg/mmol1.8 (0.7−1.9)1.0 (0.5−1.9)1.9 (0.8−5.1)\<0.0001Albuminuria, % ≥ 3 mg/mmol13.0%18.0%35.6%\<0.0001Chronic kidney disease, eGFR \< 60 or urine ACR \> 3 mg/mmol14.8%19.3%37.5%\<0.0001Elevated blood pressure, \>140 mm Hg SBP or \>90 mm Hg DBP14.8%15.9%14.0%0.6Systolic BP, mm Hg119.4 ± 14.7121.9 ± 17.1121.4 ±16.30.1Diastolic BP, mm Hg77.8 ± 10.076.2 ± 11.074.7 ± 10.10.0001Kidney failure risk No risk73.2%61.6%47.9%\<0.0001 Low risk25.7%37.1%49.5% Intermediate risk0.7%0.7%1.3% High risk0.4%0.7%1.3%[^1]

Burden of Diabetes {#sec2.2}
------------------

Among the 3 geographic groups, urban-dwelling screenees had the lowest rate of diabetes, defined as HbA~1c~ ≥ 6.5%, at 14.1%. In comparison, 28.9% of rural-dwelling individuals were diabetic, whereas 42.1% of the remote dwellers were diabetic. At the multivariate level ([Table 2](#tbl2){ref-type="table"}), rural dwellers had a 2.1 (95% confidence interval \[CI\] = 1.4−3.1) greater odds of having diabetes when compared to urban dwellers, whereas remote dwellers had a 4.1 (95% CI = 2.8−6.0) greater odds.Table 2Adjusted odds ratios and 95% confidence intervals for diabetes, elevated blood pressure, and CKD, in Indigenous Canadians of different dwelling locationsHbA~1c~ (% ≥ 6.5%)[a](#tspara0035){ref-type="p"}Elevated BP (\>140 mm Hg SBP or \> 90 mm Hg DBP)[b](#tbl2fnb){ref-type="table-fn"}CKD (eGFR \< 60 or urine ACR \> 3 mg/mmol)[c](#tbl2fnc){ref-type="table-fn"}CKD (eGFR \< 60 or urine ACR \> 3 mg/mmol)[c](#tbl2fnc){ref-type="table-fn"}^,^[d](#tbl2fnd){ref-type="table-fn"}Urban Indigenous (reference)------------Rural Indigenous2.1 (1.4−3.1)1.1 (0.7−1.6)1.2 (0.8−1.7)0.9 (0.6−1.4)Remote Indigenous4.1 (2.8−6.0)1.2 (0.8−1.9)3.1 (2.2−4.5)2.3 (1.5−3.2)[^2][^3][^4][^5][^6][^7]

Burden of CKD {#sec2.3}
-------------

Patients screened in urban areas had the lowest burden of CKD, defined as a single measurement of elevated urine ACR or eGFR \< 60 ml/min per 1.73 m^2^, at 14.8%. Comparatively, those screened in rural areas had a 19.3% prevalence of CKD, whereas those in remote communities had a 37.5% prevalence of CKD. Likewise, rates of elevated albuminuria increased with remoteness, with 13.0% of urban dwellers having albuminuria \> 3 mg/mmol, followed by 18.0% of rural dwellers, and 35.6% of dwellers in remote communities. No significant differences were found with mean eGFR or depressed eGFR (percentage with \< 60 ml/min per 1.73 m^2^), or with blood pressure. Furthermore, 52.1% of screenees in remote areas had at least some risk of kidney failure ([Supplementary Figure S1](#appsec1){ref-type="sec"}), versus 38.5% in rural areas, and 26.8% in urban areas.

[Figure 1](#fig1){ref-type="fig"} displays the distribution of screenees according to the KDIGO CKD progression risk staging system for urban dwellers, with 12.8% presenting at a moderately increased risk for CKD progression, followed by 1.9% high risk, and 0.4% very high risk for CKD progression. In comparison, [Figure 2](#fig2){ref-type="fig"} shows the distribution for rural dwellers, with 15.1% marked at moderately increased risk, 2.3% high risk, and 1.4% very high risk. Finally, [Figure 3](#fig3){ref-type="fig"} displays the distribution of CKD progression risk for the remote dwellers, with 27.4% presenting as having moderate risk, 7.7% high risk, and 1.7% very high risk.Figure 1Initial risk classification of urban-dwelling Indigenous Canadian individuals, using the Kidney Disease: Improving Global Outcomes (KDIGO) classification system. eGFR, estimated glomerular filtration rate.Figure 2Initial risk classification of rural-dwelling Indigenous Canadian individuals, using the Kidney Disease: Improving Global Outcomes (KDIGO) classification system. eGFR, estimated glomerular filtration rate.Figure 3Initial risk classification of remote-dwelling Indigenous Canadian individuals, using the Kidney Disease: Improving Global Outcomes (KDIGO) classification system. eGFR, estimated glomerular filtration rate.

In the multivariate analyses, there were no significant differences found between CKD prevalence in urban versus rural dwellers (1.2 \[95% CI = 0.8−1.7\]); however, remote dwellers had a 3.1 (95% CI = 2.2−4.5) greater odds of having CKD compared to urban dwellers, a difference that attenuated to 2.3 (95% CI = 1.5−3.2) when HbA~1c~ rates were controlled for.

Discussion {#sec3}
==========

To the best of our knowledge, this is the first primary screening initiative comparing rates of diabetes, elevated blood pressure, and CKD, in Indigenous Canadians living in urban, rural, and remote locations. Compared to urban dwellers, rural dwellers presented with a 2-fold greater prevalence of diabetes, whereas remote dwellers presented with a 4-fold greater prevalence of diabetes, and a 3-fold greater prevalence of CKD. Although the gradient in rates of diabetes and CKD suggests that geography is a social determinant of health influencing the burden of diabetes and CKD in this population, there are other determinants that geography exacerbates, such as poverty and access to care, that are likely important in affecting rates of morbidities by geographic area. Furthermore, when compared to the general Canadian population, rates of CKD were increased more than 2- and 3-fold, for rural and remote dwellers, respectively,[@bib18] and rates of diabetes 2-, 4-, and 6-fold higher for urban, rural, and remote dwellers, respectively.[@bib19] These latter findings suggest that Indigenous race is a moderating factor between geography and health outcomes.

Screening in the urban arm of this study targeted all eligible Indigenous individuals, regardless of their other underlying CKD risk factors. When compared to CKD screening studies conducted in the general population, rates were significantly elevated. For example, we found that 11.62% of the urban population had moderately increased albuminuria, and 1.41% had severely increased albuminuria. The Prevention in Renal and Vascular End-Stage Disease (PREVEND) primary screening study in the Netherlands, and the National Health and Nutrition Examination Survey (NHANES) study in the United States, found microalbuminuria ranging from 7.1% to 8.2% and macroalbuminuria ranging from 0.7% to 1.3%.[@bib20], [@bib21] Furthermore, compared to rates from a prevalence study using data representative of the Canadian population, CKD and albuminuria were also elevated.[@bib18] However, compared to screening studies of high-risk populations with underlying risk factors, such as those from the urban Kidney Early Evaluation Program (KEEP) study,[@bib22], [@bib23], [@bib24] rates of elevated albuminuria were significantly lower, and when compared to an at-risk African American population in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study in the United States,[@bib25] rates of moderately elevated albuminuria were also lower. However, rates in the urban population were elevated in comparison to an Australian screening study of high-risk individuals.[@bib26]

Several screening initiatives have found that Indigenous individuals living in rural and remote locations are faced with a substantially higher burden of diabetes and CKD. However, previous screening studies have exclusively focused on rural and remote Indigenous populations, whereas in this current study we included urban-dwelling Indigenous individuals. Compared to other screening studies of rural and remote Indigenous populations, such as those with Canadian Indigenous populations,[@bib5], [@bib27] as well as with Indigenous populations in the United States, such as Zuni,[@bib28] Navajo,[@bib29] and Pima Indians,[@bib30] rates in the urban arm were significantly lower. However, rates among screened FINISHED participants in the rural and remote locations were relatively similar to these other screened Indigenous populations.[@bib17]

Although the urban dwellers---who, in this study, all resided in low-income neighborhoods---had reduced rates of CKD and diabetes when compared to the rural and remote dwellers, when compared to the general population, they had higher rates of these outcomes. This reflects an association between income and access to health care: individuals residing in low-income urban neighborhoods are less likely to have access to preventive health care services,[@bib31] are less likely to have a regular health care provider,[@bib32] and consequently have poorer health outcomes.[@bib33] This relationship is confounded with rurality; it is established that there is a significant divide in health status between urban and rural settings, with rural dwellers generally having poorer health overall when compared to urban dwellers.[@bib34] Rural dwellers with CKD have reduced access to primary care and nephrology specialists, and consequently, they are more likely to reach end-stage renal disease,[@bib35] and are more likely to die or be hospitalized, when compared to individuals who live closer to specialized care.[@bib36] Therefore, when taken together, these findings suggest that rurality does not unilaterally cause the health disparities that rural and remote dwellers are faced with, but rather there is an interplay among other factors, such as poverty, that aggravate the relationship between dwelling location and poor health outcomes.[@bib37]

Further adding to this complex relationship, Indigenous Canadians are at a socially constructed disadvantage.[@bib38] They are more likely to live in poverty, and are more likely to live in remote areas, with poverty rates worsening as communities become more isolated.[@bib39] Indigenous Canadians are also more likely to reside in households that are faced with food insecurity,[@bib40] which is a significant risk factor for diabetes and CKD.[@bib41], [@bib42] Although this is a significant issue that those living in low-income urban neighborhoods are faced with, Indigenous people who reside in remote and rural areas are disproportionately faced with this barrier.[@bib43], [@bib44]

However, it remains unclear as to the full extent to which geography alone is a social determinant driving these health disparities for Indigenous people in rural and remote areas, or whether geography is a surrogate exacerbating these inequalities. Indigenous Canadians living in Indigenous communities outside of urban areas are *de facto* served by a separately funded health system governed by separate agreements and policies that may functionally impose additional barriers, particularly with regard to accessing consultation and specialist services,[@bib45], [@bib14] further contributing to a gradient of worsening health outcomes.[@bib46] However, it is in the most remote areas that federal jurisdiction limits access to services and resources the most severely. Nevertheless, the role of geography alone as a driver of health inequalities should not be overstated, given that Indigenous Canadians residing in urban areas are also faced with significant health inequalities. When compared to the general population, urban-dwelling Indigenous Canadians have worse health outcomes, despite having the same geographic access. This, juxtaposed against the geographic barriers to accessing health services that rural and remote dwellers are faced with, suggests that there are systemic barriers embedded within the health care system[@bib47] that make accessing health care services more difficult, despite having geographic access to them.[@bib4], [@bib48]

To improve quality of life and health outcomes, it is imperative to identify and address the underlying systemic factors that drive the higher rates of CKD and other comorbidities found in Indigenous populations of different geographic locales, allowing for upstream screening and treatment of early-stage CKD and its risk factors. Although our study is an important first step in this direction in suggesting that there are underlying mechanisms beyond geography that affect rates of diabetes and CKD, our study does not provide a better understanding of the exact mechanism(s). In particular, although it is generally accepted that a history of colonialism and its legacy of structural racism is an active precipitator of poor health outcomes in Indigenous people,[@bib49], [@bib50], [@bib51] more research across different disciplines, as well as a broader discourse, is needed to concretely identify the pathway that a history of colonialism has as a social determinant on Indigenous Canadians' health.

Our findings have clinical, research, and policy implications. First, from a clinical perspective, the prevalence of diabetes and chronic kidney disease appear to be elevated in Indigenous Canadians of different dwelling locations, suggesting that primary screening programs are cost-effective in this population.[@bib52] Furthermore, more research needs to be conducted on how geography interplays with other health determinants, such as genetics, the environment, and sociodemographic factors---in particular, poverty---to affect CKD rates. Finally, from a health policy perspective, access to CKD care, as well as to primary care, needs to be improved for Indigenous individuals through health services delivery strategies that consider access barriers that Indigenous Canadians are disproportionately faced with, such as geographic and economic barriers,[@bib53] as well as through health promotion strategies. Research has shown that many individuals residing in Indigenous communities are unaware of their underlying health problems, in particular their risk of developing CKD.[@bib5]

It should be acknowledged that this study has both strengths and limitations. Although other screening studies of Indigenous individuals have compared rates of diabetes, elevated blood pressure, and CKD, between rural and remote dwellers, to the best of our knowledge, this is the first study to include a cohort of Indigenous urban dwellers. The screening was conducted using a well-defined screening protocol, finding CKD rates that were comparable to other high-risk populations for whom screening is recommended.[@bib54] However, as both screening initiatives recruited individuals through convenience sampling, there is a possibility of selection bias. In the remote communities, lower screening rates were observed compared to the rural communities, likely attributed to differences in transportation and health services availability in these areas. In the urban arm of the study, although we sampled individuals from neighborhoods with a large proportion of Indigenous people, it is unknown whether this sample is reflective of other Canadian cities, and therefore participants may not be fully representative of all urban Indigenous individuals. Another limitation that is also shared by many clinical studies is that of self-selection bias; when compared to the general population, individuals who self-select to participate in screening initiatives tend to be healthier, which would bias our results by underestimating disease prevalence. Conversely, individuals who are aware of their CKD risk factors may also be more likely to participate in screening, which would overestimate prevalence rates. It is unclear as to what the net effect of these biases would be on prevalence estimates. Finally, based on a single measurement, we presumed chronicity, whereas a confirmed CKD diagnosis would require reduced eGFR or albuminaria sustained over 3 months. However, other large community screening studies also share this limitation.

Conclusion {#sec4}
==========

When compared to the general population, Indigenous Canadians display a high prevalence of diabetes and chronic kidney disease. However, geography, as a surrogate exacerbating other social determinants of health, plays an important role in affecting the severity of the diseases, with a striking gradient of worsening rates from urban to rural to remote. Further research needs to be conducted to explore the underlying mechanisms responsible for the disparities in diabetes and CKD that are faced by Indigenous Canadians in different geographic areas.
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**Figure S1.** Criteria for determining kidney failure risk.
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[^1]: DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA~1c~, glycated hemoglobin; SBP, systolic blood pressure. Summary statistics given as mean ± SD for normally distributed variables, median (interquartile range) for non−normally distributed variables, and percentages (n) for categorical variables. Some categories may not sum to 100% due to rounding. The criteria for determination of kidney failure risk are presented in [Supplementary Figure S1](#appsec1){ref-type="sec"}.

[^2]: ACR, albumin to creatinine ratio; BP, blood pressure; CKD, chronic kidney disease; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA~1c~, glycated hemoglobin; SBP, systolic blood pressure.

[^3]: Age and sex controlled for in all analyses.

[^4]: Reference: ^a^HbA~1c~ % \< 6.5%.

[^5]: Low BP.

[^6]: No CKD.

[^7]: Controlled for age, sex, and HbA~1c~.
